In the setting of TB and HIV co-infection, the sensitivity of sputum smear microscopy is even lower (~35%). [3] The high false-negative rate causes delays in diagnosis and therapeutic intervention, and may lead to further spread of the disease.
Definitive diagnosis of disseminated TB poses a challenge owing to atypical clinical presentations, and often a negative chest radiograph and negative findings on sputum microscopy and culture. This necessitates invasive procedures such as bone marrow aspiration (BMA), bone marrow trephine (BMT) biopsy, soft-tissue biopsy, lumbar puncture, etc.
TB culture is considered to be the gold standard for definitive diagnosis, but the turnaround time is undesirably long (up to 6 weeks), which has an adverse impact on infection control. [3] Microscopic examination of the BMA smears and BMT biopsy specimens offers a far more rapid diagnostic strategy, where results can be available on the same day for the former and within 4 days for the latter. The diagnosis of TB in the bone marrow is made microscopically by the identification of granulomas and/or AFB by Ziehl-Neehlsen (ZN) staining in the BMT biopsy sections. ZN staining is not currently routinely performed on BMA samples owing to its low sensitivity. However, auramine O staining is reportedly more sensitive than ZN in sputum, [4] and may offer a higher yield in BMA samples as well.
Objective
To compare the diagnostic yield for TB between the BMA smear and BMT biopsy specimen against TB culture as the gold standard, and thereby identify a potentially faster and more effective diagnostic strategy for a resource-poor setting. The study population comprised 410 adult and paediatric patients who had a BMA smear and BMT biopsy specimen submitted for analysis to exclude MTB infection. Clinical data were obtained from the bone marrow request forms completed by clinicians, and results were retrieved from the laboratory information system (DisaLab version 04.16.04.373). BMA slides from BMA samples submitted to the National Health Laboratory Service (NHLS) for TB testing were stained with auramine O. The results of the latter were compared with those of BMT biopsy specimen microscopy and BMA TB culture.
Methods
BMA smears were stained with Giemsa for conventional microscopy and with auramine O for detection of AFB using fluorescent microscopy. BMT sections were stained with haemotoxylin and eosin for conventional microscopy. The presence of granulomas necessitated further staining for detection of infective organisms at the discretion of the reporting pathologist. TB culture was done on BMA samples inoculated into special Myco-Flytic culture vials during the BMA procedure. These were then incubated in the Bactec 9240 automated system and inspected weekly for 6 weeks.
The diagnosis of bone marrow TB was made on the basis of one or more of the following criteria: (i) positive TB culture of bone marrow; (ii) detection of granulomas and/or AFB on the BMT biopsy specimen; and (iii) detection of AFB on the BMA sample using the auromine-O staining method. Exclusion criteria were: (i) samples not inclusive of all test methods, viz. BMA auramine O staining, BMT biopsy specimen staining and TB culture; and (ii) suboptimal quality samples.
Statistical analysis
Statistical analysis was performed using STATISTICA software, version 12.0 (Stat Soft (Pty) Ltd). Data are presented as medians (interquartile range (IQR)) and proportions, as appropriate. Sensitivity and specificity were calculated for each test method using TB culture as the gold standard. The Mann-Whitney U-test was used to compare continuous variables of interest. The level of statistical significance was taken as p≤0.05.
Results

Characteristics of the cohort
Results from a total of 410 patient samples were analysed ( Table 1) .
Characteristics of patients diagnosed with tuberculosis
Out of the 410 patient samples, 123 were positive for TB. Of the samples in which a BMA/BMT biopsy was performed specifically to investigate for TB, 32.5% were positive for TB. The remainder of the patients with TB-positive samples had cytopenias (57.7%) and haematological malignancies (0.95%) ( Table 2) .
Of the 123 samples that were positive for TB, 7 (5.7%) were diagnosed on BMA auramine O staining, 97 (78.9%) had granulomas on the BMT biopsy specimen, and 63 (51.2%) were positive on TB culture. ZN staining was performed in only 90 cases (73.2%), and was found to be positive for AFB in 38 (42.2%). Sensitivity and specificity results for the various methods are set out in Table 3 . The organism identified on TB culture was MTB in 58 (92%) of cases, and M. avium intracellulare complex in the remaining 5. All the BMA auramine O-positive cases with a positive TB culture were positive for MTB.
Of the 347 patients with samples negative for TB culture (84.6%), 83 (23.9%) had TB diagnosed by examination of BMA/BMT biopsy specimens. This is an interesting finding with respect to TB culture being the gold standard. In contrast, of the 63 patients with positive TB culture results, 56 (88.9%) had a negative BMA auramine O stain, 28 (44.4%) had no granulomas on the BMT biopsy specimen, and 20 (of an available 37) (54.1%) were negative for AFB on ZN staining (Table 4) .
In order to assess the value added by each of the four methods, test positivity rates in isolation were calculated, viz. TB culture n=24 
Discussion
TB remains a significant health problem, the detection of which requires prompt diagnosis. TB culture-based algorithms for diagnosis are relatively expensive [5] and have an unacceptably long turnaround time. Current rapid methods quoted in the literature include rapid liquid culture systems, [3] nucleic acid amplification tests [6] and the microscopic observation susceptibility assay. [7] Studies have also recently shown that in HIV-positive patients with CD4 cell counts <100 cells/µL, the TB lipoarabinomannan urine test can detect over half of culture-positive TB patients in less than 30 minutes. [8] In the SA setting, the GeneXpert MTB/RIF assay has become widely available, and reportedly performs better than smear microscopy where TB and HIV are both highly endemic. [9] However, these tests are generally expensive and require specialised equipment and expertise, and to date none has been validated on BMA and BMT biopsy samples. In this study, we evaluated the role of BMT biopsy specimen examination and BMA auramine O staining in reducing the time taken to establish a diagnosis of disseminated TB, using TB culture as the gold standard.
Over 95% of the patients with disseminated TB were HIV-positive, with a median CD4 count of 33 cells/µL. Approximately a third of these patients had a BMA/BMT biopsy performed to investigate for possible TB, and over half had unexplained cytopenias. The sensitivity for detecting TB was highest for histological examination of BMT biopsy specimens (56%), followed by ZN staining (46%), and least sensitive for auramine O staining of BMA samples (9.3%). Interestingly, the median CD4 counts in HIV-positive patients with TB diagnosed by auramine O staining of BMA samples were significantly lower than those in patients diagnosed with the other test methods, possibly reflecting a higher TB bacillary load as a consequence of immune compromise. Although the BMA auramine O method is rapid and showed excellent specificity, its sensitivity is too low for it to be advocated for routine practice. The reasons for the poor yield using this method are likely to be multifactorial, including poor quality of BMA samples, reduced macrophage activity on the BMA smear and overall poor sensitivity of the test method.
The utility of BMT biopsy specimen examination in the setting of HIV/ TB co-infected patients was reported on previously by Akpek et al., [10] who showed that although the diagnostic sensitivity of bone marrow cultures was equal to that of blood cultures, histological examination of bone marrow resulted in rapid identification of nearly one-third of infected patients who underwent bone marrow examination, and that infection was identified in some patients who were culture-negative. In our study, examination of BMT biopsy specimens proved highly valuable; approximately half of the cases of TB were diagnosed microscopically without a positive TB culture, and the diagnosis was expedited in over 60% of patients in whom the TB culture was positive. Nevertheless, over one-third of patients with a positive TB culture had no bone marrow morphological abnormalities, highlighting the potential utility of molecular techniques in this setting.
Conclusion
We found that histological examination of BMT biopsy specimens had a significantly higher detection rate than auramine O staining of BMA samples, compared with the gold-standard TB culture in our setting, where there is a high HIV burden. We recommend that BMT biopsies remain an essential part of the diagnostic work-up for disseminated TB. However, as microscopic examination failed (p<0.0001) to detect a substantial proportion of cases in whom TB culture was positive, other rapid molecular techniques such as GeneXpert are required. 
